Scheter 2019.
Study characteristics | ||
Methods | Retrospecting single‐centre matched cohort January 2011 to December 2016 Tel‐Aviv Sourasky Medical Center, Tel Aviv, Israel 24 participants |
|
Participants |
Inclusion: Patient with breast cancer with central tumours undergoing breast‐conserving surgery Exclusion: Patients who had subsequently proceeded to total mastectomy |
|
Interventions |
Intervention: Volume displacement ‐ mammoplasty, (n = 12) Control: BCS: WLE, (n = 12) |
|
Outcomes |
Primaryoutcomes:
Secondaryoutcomes:
Other outcomes:
|
|
Notes | Declaration: One author is a speaker for Johnson Medical, no financial or personal declarations No funding declared |